Ibrance 75 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F23T1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,123
Award facts
- Contract value 100% obligated
- $17,122.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $17,122.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Ibrance 75 mg capsules (21-count packages), with delivery expected by December 23, 2025. This competitive award carries no set-aside designation and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999.999 billion global pharmaceutical supply vehicle valued through December 2026 that enables the company to furnish an extensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated substantial capability through its portfolio of competitively awarded federal contracts covering diverse pharmaceutical products and medical supplies. As the prime contractor on the DLA Troop Support Medical IDC, the company supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of this Ibrance delivery order reflects the company's role as a primary source for pharmaceutical support within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26F23T1?
SPE2DR26F23T1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F23T1 worth?
The government has obligated $17,123 on SPE2DR26F23T1.
Is contract SPE2DR26F23T1 an order under another contract?
Yes. SPE2DR26F23T1 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F23T1 competed?
The extent of competition for SPE2DR26F23T1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award